ETERN Therapeutics
PrivateLast Round
Series B
Extension
Jun 26, 2026
Total Funding Raised
$13.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ETERN Therapeutics is a biotechnology company that develops novel small molecule drugs targeting undruggable proteins using a proprietary liquid-liquid phase separation (LLPS) technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ETERN Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ETERN Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 26, 2026 | ||||
| Series B Extension | Apr 1, 2024 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A | Apr 9, 2020 | ||||
| Angel | Dec 31, 2018 | ||||
Angel | Dec 1, 2018 |
ETERN Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Series B |
| TF Capital | Series B, Series A |
| Morningside Ventures | Series B |
| Wuxi High-tech Zone Venture Capital Holding Group | Series B Extension |
| BOHE Angel Fund | Series A |
| Wuxi Capital Group Co.,Ltd | Series B Extension |
| Apricot Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 59% MoM.
- Sep 1, 2021
Led by Hillhouse Investment and Astrazeneca-CICC Healthcare Industrial Fund.
ETERN Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ETERN Therapeutics's valuation, stock price, and market status.